2017 年 5 月 (No71) の記事要旨と参考文献

Transcription

1 2017 年 5 月 (No71) の記事要旨と参考文献 参考文献はアクセスが容易になるように できる限りネットへのリンクをつけたものにしています ( 特に PubMed アブストラクトへリンクできるよう ) P50 1

2 Editorial p51 Free 総説 p52-53 参考文献 1) マンモグラフィーによる乳がんスクリーニング (Part 1). Prescr Int. 2015, 24(158): ( 抄訳 : 薬のチェック TIP. 2016, 16(63): ) 2) 同 (Part2,3): 同上 2015, 24(159):99-101,24(162): ( 抄訳 : 同,2016, 16(66):92-94) 3) 薬のチェック TIP 編集委員会 マンモグラフィー検診は受けなくてよい. 薬のチェック TIP. 2016: 16(67): 118 4) Donker M, Litière S, Werutsky G, Julien JP et al. Breast-conserving treatment with or without radiotherapy in ductal carcinoma In Situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC randomized phase III trial. J Clin Oncol Nov 10;31(32): ) Wapnir IL, Dignam JJ, Fisher B et al. Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J Natl 2

3 Cancer Inst Mar 16;103(6): ) Fisher B, Costantino JP, Wickerham DL et al Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst Sep 16;90(18): ) Cuzick J, Powles T, Ve ronesi U et al. Overview of the main outcomes in breast-cancer prevention trials. Lancet Jan 25;361(9354): ) Cuzick J, Sestak I, Cawthorn S, Hamed H, Holli K, Howell A, Forbes JF; IBIS-I Investigators. Tamoxifen for prevention of breast cancer extended long-term follow-up of the IBIS-I breast cancer prevention trial. Lancet Oncol Jan;16(1): P54-57 Web 資料あり参考文献 1. 薬害オンブズパースン会議 WHO ワクチン安全性諮問委員会 (GACVS) の HPV ワクチンに関する声明 (2015 年 12 月 17 日付 ) に対する反論 _ _japanese.pdf Gøtzsche PC, Jefferson T, Auken M, Brinth L. Complaint to the European ombudsman over maladministration at the European Medicines Agency (EMA) in relation to the safety of the HPV vaccines. [accessed ] 3. Quinn M, Babb P, Jones J, Allen E.Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics. BMJ Apr 3;318(7188): Shastri SS, Mittra I, Mishra GA, Gupta S, Dikshit R, Singh S, Badwe RA. Effect of VIA screening by primary health workers: randomized controlled study in Mumbai, India. J Natl Cancer Inst Mar;106(3):dju009. doi: /jnci/dju HPV screening for cervical cancer in rural India. 3

4 Sankaranarayanan R, Nene BM, Shastri SS, Jayant K, Muwonge R, Budukh AM, Hingmire S, Malvi SG, Thorat R, Kothari A, Chinoy R, Kelkar R, Kane S, Desai S, Keskar VR, Rajeshwarkar R, Panse N, Dinshaw KA. N Engl J Med Apr 2;360(14): doi: /NEJMoa Sankaranarayanan R, Esmy PO, Rajkumar R, Muwonge R, Swaminathan R, Shanthakumari S, Fayette JM, Cherian J.Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial.lancet Aug 4;370(9585): 人口動態統計 8. 浜六郎ら 子宮頸がんの疫学と HPV ワクチン The Informed Prescriber 2013:28(2): Kripke DF, Garfinkel L, Wingard DL et al. Mortality associated with sleep duration and insomnia. Arch Gen Psychiatry Feb;59(2): Klerman EB, Dijk DJ. Age-related reduction in the maximal capacity for sleep--implications for insomnia. Curr Biol Aug 5;18(15): file:///c:/users/roku/downloads/srep35812.pdf 11. Kitamura S, Katayose Y, Nakazaki K et al. Estimating individual optimal sleep duration and potential sleep debt. Sci Rep Oct 24;6: 浜六郎 薬のやめ方 事典 三五館 2017 p57 p

5 参考文献 1) Laing KJ et al. Zoster vaccination increases the breadth of CD4+ T cells responsive to Varicella zoster virus. J Infect Dis 2015;212: ) Gagliardi AM et al. Vaccines for preventing herpes zoster in older adults. Cochrane Database Syst Rev Mar 3;3:CD ) Tseng HF et al. Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease. JAMA 2011;305: ) Oxman MN et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005;352: ) Schmader KE et al. Persistence of the efficacy of zoster vaccine in the shingles prevention study and the short-term persistence substudy. Clin Infect Dis 2012;55: ) Morrison VA et al. Long-term persistence of zoster vaccine efficacy. Clin Infect Dis 2015;60: ) Lai YC, Yew YW. Severe autoimmune adverse events post herpes zoster vaccine: a case-control study of adverse events in a national database. J Drugs Dermatol 2015;14: ) Tseng HF et al. Herpes zoster vaccine and the incidence of recurrent herpes zoster in an immunocompetent elderly population. J Infect Dis 2012;206: ) Le P, Rothberg MB. Cost-effectiveness of herpes zoster vaccine for persons aged 50 years. Ann Intern Med 2015;163: ) Cunningham AL et al. Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older. N Engl J Med 2016;375: ) 浜六郎 アジュバントって何? 薬のチェックは命のチェック 2014:14(53): (Free) 5

6 P62 以下記事を 参考文献参考文献 1) Prescrire Editorial Staff Irritable bowel syndrome. A mild disorder; purely symptomatic treatment Prescrire Int 2009; 18 (100): ) EMA - CHMP Assessment report for linaclotide. EMEA/H/C/ September 2012: 3) US FDA - CDER Application Number: Orig1s000 - Medical Review(s) 16 August 2012: 4) Rao S et al. A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation Am J Gastroenterol 2012; 107 (11): ) Chey WD et al. Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety Am J Gastroenterol 2012; 107 (11): ) European Commission SPC-Constella 20 February 2014: 11 pages. 7) Lembo AJ et al. Two randomized trials of linaclotide for chronic constipation N Eng J Med 2011; 365 (6): ) Lin JE, Valentino M, Marszalowicz G et al. Bacterial heat-stable enterotoxins: translation of pathogenic peptides into novel targeted diagnostics and therapeutics. Toxins (Basel) Aug;2(8): )Ford AC, Suares NC.Effect of laxatives and pharmacological therapies in chronic idiopathic constipation: systematic review and meta-analysis. Gut 2011;60(2): ) 薬のチェック TIP 編集委員会 ルビプロストン ( 商品名 : アミティーザ ): 使用不可 害が大きすぎる 薬のチェック TIP 2015:15(59): P63 Prescrire 評価 薬のチェック TIP 評価 6

7 P65 参考文献 1) Health Canada Summary safety review Over the counter products containing pseudoephedrine-assessing the potential risk of inflammation and injury of the large intestine due to insufficient blood supply(ischemic coliris) 24 February 2016; 2pages. 2) Prescrire Redaction Patients sous vasoconstricteur decongestionnant Rev Prescrire 2016;36(386 suppl Interactions medicamenteuses). 3) Sherid M et al. Pseudoephedrine-induced ischemic colitis :case report and literature review J Digest Dis 2014; 15: ) Prescrire Editorial Staff Ischaemic colitis on pseudoephedrine Prescrire Int 2001; 10(54):117. P66 以下本文を 7

8 参考文献 1) ANSM Reunion du comite technique de pharmacovigilance, compte rendu de la seance du 15 decembre Suivi batuibak de ogarnacivugukabce des soecuakutes a base de sofosbuvir et daclatasvir Sovaldi Harvoni Daklinza 9 January 2016; ) Renard S et al. Severe pulmonary arterial hypertension in patients treated for hepatitis C with sofosbuvir Chest 2016; 149(3): ) Savale L et al. Direct-acting antiviral medications for hepatitis C virus infection and pulmonary arterial hypertension Chest 2016; 150(1): ) Prescrire Redaction Notice Harvoni (sofosbuvir+ledipasvir):quasiabsence d information surles effects indesirables Rev prescrire 2016; 36(389):223. 5) European Commission SPC-Harvoni 22 July 2016; 53pages. 6) European Commission SPC-Sovaldi 28 January 2016; 44pages. P66 参考文献 1) Health Canada Summary Safety Review AVASTIN(bevacizumab)-Assessing the Potential Risk of Irreversible Vocal Cord Damage(vocal cord necrosis) 30 November February 2016:2page 2) Kountourakis P et al. Voice disorders induced by bevacizumab administration in an ovarian cancer patient: an underestimated and rare toxicity Hematol Oncol Stem Cell Ther 2014;7(3): ) Saavedra E et al. Dysphonia Induced by anti-angiogenic compounds Investigational New Drugs 2014;32(4): P67 参考文献 1) FDA Drug Safety Communication: FDA warns about several safety issues with opioid pain medicines 22 March 2016: 11pages. 2) Debono M et al. Tramadol-induced adrenalinsufficiency Eur J Clin Pharmacol 2011:67: ) Opioid analgesics. In: Martindale The Complete Drug Reference The Pharmaceutical press, London. accessed 17 Aprill 2016:21pages. 4) Prescrire Editorial Staff Opioid and hypogonadism Prescrire Int. 2012;21(126): ) Lee AS and Twigg SM Opioid-induced secondary adrenal insufficiency presenting as hypercalcaemia Endocrinol Diabetes Metab 2015:5pages. 6) Policola C et al. Adrenal insufficiency in acute oral opiate therapy Endocrinol Diabetes Metab 2014:3pages. 8

9 P68-69 P70 連載 : 医薬品危険性情報 あれこれ 日本の国立医薬品食品衛生研究所が発行している 医薬品安全性情報 ( 海外規制 機関 ) から薬剤の害反応を紹介し 本誌編集委員がコメントする WHO デノスマブ : 血管炎 カナダ Health Canada インターフェロン ß 製剤 : 肺動脈性肺高血圧 英 MHRA C 型肝炎治療用の直接作用型抗ウイルス剤 : ビタミン K 拮抗剤との相互作用により PT-INR 変動が生じるリスク P71 つくられた恐怖の点滴殺人事件守大助さんは無実だ P72 編集後記 9